Consult Dr. Gold

Patents

UNITED STATES PATENTS:

  • Redmond, Gold, Kleber. Method of eliminating opiate withdrawal symptoms with clonidine in humans. Patent #: 4/312,878. Issued: January 26, 1982
  • Brompocriptine method of eliminating cocaine withdrawal. #731,102 and #791,188 (see Dackis and Gold, Lancet 1(8438)1151-1152, 1985
  • Method of eliminating amphetamine and cocaine withdrawal with dopamine agonists #20, 1941.2,1986. (Gold and Dackis Clin Ther 7(1):6-21, 1984)
  • Marker Detection Method and Apparatus to Monitor Drug Compliance #60/164,250, Filed November 8, 2000
  • Method and Apparatus for Detecting Illicit Substances #60/292,964 filed May 23, 2001
  • Methods and Apparatus for Therapeutic Drug Monitoring using Exhaled Breath #10/788,501 filed February 26, 2004
  • Novel Methods and Apparatus for Therapeutic Drug Monitoring Using Exhaled Breath # 10/788, 501, Filed February 26, 2004
  • Methods and Systems for Preventing Diversion of Prescription Drugs- #11/578,332, Filed September 20, 2004
  • System and Method for Monitoring Health Using Exhaled Breath – #11/301, 911, Filed December 13, 2005. Docket No. 10457-136CIP, UF#11973. Election filed in response to restriction requirement on March 4, 2010
  • Method and Apparatus for Detecting Environmental Smoke Exposure #7/052,468, Filed May 30, 2006
  • System and Method for Monitoring Health Using Exhaled Breath (Propofol Claims) #11/512, 856, Filed August 29, 2006
  • A Novel System for Monitoring Environmental Contamination from Controlled Substances U11458
  • Diagnosis and Treatment of Neurological Inflammation WO 2008/008819
  • System and method for monitoring health using exhaled breath # 20070167,853, Filed July 19, 2007
  • Devices and Methods for the Collection and Detection of Substances on Surfaces and Air # 60/971,451. Filed September 11, 2007
  • System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring # 20070258894 filed November 7, 2007
  • Methods and Systems for Preventing Diversion of Prescription Drugs #20080059226 filed March 6, 2008
  • Devices and Methods for the Collection and Detection of Substances (Gold MS, Martin DM, Gold ST, Goldberger BA, Rao A.) Serial No. 12/208,896; filed September 11, 2008. UF #-12604. US Patent # 8,414,846; issued April 9, 2013
  • Medication Adherence Monitoring System PCT/US08/054755; filed February 22 2008; Provisional application: US 60/891,085, filed 22 February 2007; Our docket No. 10457-132JP; UF# 12393; Patent Application Publication (Melker, Dennis, Batich, Gold), Pub No.: US 2010/0255598 AI, Pub. Date: Oct. 7, 2010
  • Balclofen/Naltrexone Combination Therapy for suppressing Binge Eating of Palatable Food UF#-13854; filed December 14, 2011, (Avena and Gold).
  • Compositions for Controlling Food Intake and Uses Therefor (Mark S. Gold and Nicole M. Avena). Patent # 9,610,285 B2. Issued April 4, 2017.

INTERNATIONAL PATENTS

  • Method and Apparatus for Detecting Illicit Substances PCT/US02/161157, filed May 22, 2002
  • Method and Apparatus for Detecting Environmental Smoke Exposure PCT/US02/16153 filed May 22, 2002
  • System and Method for Real-Time Diagnosis, Treatment, and Therapeutic Drug Monitoring PCT/US05/06355, Filed March 17, 2005
  • Intelligent Drug and/or Fluid Delivery System to Optimizing Medicial Treatment or Therapy Using Pharmacodynamic and/or Pharmacokinetic Data. (Melker R)  International Application Number: PCT/US11/48083 EFS ID: 14967843
  • European Appln No. 06849923.5  System and Method for Monitoring Health Using Exhaled Breath (Melker, Dennis, Bjoraker, Gold) Our Docket No. 10457-135EP; SLS Docket No. 270C4EPO. UF#11973
  • Canadian Appln No. (not yet assigned) System and Method for Monitoring Health Using Exhaled Breath (Melker, Dennis, Bjoraker, Gold) Our Docket No. 10457-135CA; SLS Docket No. 270C4EPO. UF#11973
  • Medication Adherence Monitoring System. (Melker, Dennis, Batich, Gold) Application No: PCT/US 2008/054755 Application filing date: 2008/02/22; Date application made available for public inspection: 2008/8/28; Date on which patent was granted and issued: 2012/11/13. Canadian patent number: 2,678,969
  • Central Site Photoplethysmography, Medication Administration, and Safety. (Melker R, Dennis, Melker J, Rice, Hurley, Gold, Allen). International application no: PCT/US2011/046943 Application filing date: 08.08.2011 International Publication Number WO 2012/024106 A2 International Publication Date: 23.02.2012
Mentees Yale University School of Medicine Professor Brian Fuerhlein MD, PhD. and Johns Hopkins Chris Hammond, MD, PhD.

Mentees Yale University School of Medicine
Professor Brian Fuerhlein MD, PhD. and Johns Hopkins Chris Hammond, MD, PhD.

Mentee and Collaborator on Methamphetamine Jean Lud Cadet, MD , NIDA Chief, Neurpharmacology

Mentee and Collaborator on Methamphetamine
Jean Lud Cadet, MD , NIDA Chief, Neurpharmacology

DEA Panel on Cocaine and Cocaine – Related Deaths

DEA Panel on Cocaine and Cocaine – Related Deaths

Lifetime Achievement Award Presentation, NYC, Chairman USC Dr. David Baron, DO & Kenneth Blum PhD.

30 Year of Service Award to the DEA Presented to Dr Gold by Tom Harrigan , DEA